M. Costuleanu et al., EFFECTS OF LIPOSOME-ENTRAPPED PLATELET-ACTIVATING-FACTOR IN THE ISOLATED RAT TRACHEA, European journal of pharmacology, 281(1), 1995, pp. 89-92
The effects of platelet-activating factor (PAF, alkyl-2-acetyl-sn-glyc
ero-3-phosphocholine)-filled liposomes upon rat tracheal rings in vitr
o were examined. The capture of liposomes by the smooth muscle cells o
f the isolated tracheal rings as well as the release of their content
into the cytoplasm was shown by using Evans blue (5 x 10(-4) M)-loaded
liposomes. Administration of PAF (10(-3) M)-filled liposomes contract
ed the preparations, in contrast with extracellular administration of
PAF and control liposomes, which had no effect. Administration during
the plateau or pretreatment with liposomes containing BN 52021 ymethan
o-1H,6aH-cyclopenta[c]furo(2,3-b)furo[3',2' :3,4]cyclopental [1,2-d]fu
ran-5,9,12(4H)-trione) ((10(-3) M, a selective PAF receptor antagonist
) or heparin (5 x 10(-5) M) blocked this contraction. BN 52021 and hep
arin, not entrapped in liposomes, had no such effect. Our data suggest
an intervention of PAF in the mechanisms of contraction of tracheal s
mooth muscle, involving a direct or indirect intervention (intracellul
ar receptors for PAF cannot be excluded). At the same time, the rat tr
achea contraction induced by PAF-loaded liposomes could be linked to t
he PtdIns(1,4,5)P-3-dependent Ca2+ channels from the endoplasmic retic
ulum and/or to the interaction with G proteins, as shown by the blocki
ng effects of heparin-containing liposomes.